Overview Both GHRP-2 (pralmorelin/KP-102) and GHRP-6 are synthetic hexapeptides that stimulate growth hormone release from the anterior pituitary through the growth hormone secretagogue receptor type 1a (GHSR-1a) the ghrelin receptor (Howard et al., 1996)
and the 2024 Monitoring Program, which includes substances that are not on the List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport
NAD + functions as a metabolic driver of circadian transcription via epigenetic mechanisms, transducing signals originated by environmental stimuli to the circadian clock
Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons
Other methods of targeting aSYN concentrate on extracellular aSYN binding sites, inhibitors of aSYN aggregation, or promoters of aSYN clearance via the LAS, although they have not yet advanced to the stage of clinical development